Adamis Pharmaceuticals Corp

Company Snapshot: Adamis Pharmaceuticals Corp

Last Change Volume High Low

Company Overview

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) is a biopharmaceutical company engaged in the development and commercialization of specialty pharmaceutical and biotechnology products in the therapeutic areas of respiratory disease, allergy, oncology and immunology. In its specialty pharmaceutical pipeline, ADMP is developing low cost therapeutic alternatives for the treatment of anaphylaxis, asthma, chronic obstructive pulmonary disease (COPD) and allergic rhinitis. Within the Company's biotechnology pipeline is a novel cell-based therapeutic cancer vaccine and three drug candidates for the treatment of prostate cancer.

Client News

  1. Nov 14 2022 Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
  2. Nov 7 2022 Adamis Pharmaceuticals Schedules Third Quarter 2022 Financial Results Conference Call and Corporate Update
  3. Oct 3 2022 Adamis Announces Review of Strategic Alternatives
  4. Sep 21 2022 Adamis Provides Update on the Phase 2/3 Trial of Tempol in COVID-19 Positive High-Risk Subjects